Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · IEX Real-Time Price · USD
5.85
+0.13 (2.27%)
At close: Apr 22, 2024, 4:00 PM
5.75
-0.10 (-1.71%)
After-hours: Apr 22, 2024, 5:57 PM EDT

Travere Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-111.4-278.48-180.09-169.43-146.43-102.68-59.73-47.9117.24-110.94
Upgrade
Depreciation & Amortization
38.5320.7212.7524.5820.4119.1217.816.1413.395.4
Upgrade
Share-Based Compensation
44.2538.1429.5723.6121.1119.7726.8729.125.915.9
Upgrade
Other Operating Activities
-251.433.33122.9978.546.738.8222.46-0.78-157.9243.79
Upgrade
Operating Cash Flow
-280.02-186.29-14.79-42.74-58.21-24.967.4-3.44-1.39-45.85
Upgrade
Capital Expenditures
-42.26-28.56-24.15-24.57-15.57-19.7-14.01-11.92-7.03-3.96
Upgrade
Acquisitions
000-95.28000-0.62-33.43-29.15
Upgrade
Change in Investments
-109.37-3.4-113.4758.5235.43-183.5959.6122.91-188.55-4.06
Upgrade
Other Investing Activities
207.4-0.6------148.41-0.09
Upgrade
Investing Cash Flow
55.78-32.55-137.62-61.3319.86-203.2945.610.37-80.6-37.26
Upgrade
Share Issuance / Repurchase
222.2327.11239.89137.463.417.6111.7310.02160.7846.14
Upgrade
Debt Issued / Paid
095.04000226.9800-4554.01
Upgrade
Other Financing Activities
-3.48-4.58-8.2-9.75-5.47-12.72-6.29-13.87-14.18-4.83
Upgrade
Financing Cash Flow
218.75117.57231.68127.71-2.08231.865.45-3.85101.695.32
Upgrade
Exchange Rate Effect
1.98-2.791.71-1.31-0.01-0.14-0.060.12-0.010
Upgrade
Net Cash Flow
-3.51-104.0780.9822.34-40.443.4858.393.219.612.21
Upgrade
Free Cash Flow
-322.28-214.85-38.94-67.31-73.78-44.66-6.61-15.37-8.42-49.81
Upgrade
Free Cash Flow Margin
-221.90%-196.28%-29.54%-33.94%-42.08%-27.19%-4.26%-11.50%-8.43%-176.63%
Upgrade
Free Cash Flow Per Share
-4.34-3.37-0.65-1.42-1.74-1.10-0.17-0.41-0.25-1.99
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).